Polydeoxyribonucleotides (PDRNs) are a family of DNA-derived drugs with a molecular weight ranging from 50 to 1500 kDa, which are mainly extracted from the sperm cells of salmon trout or chum salmon. Many pre-clinical and clinical studies have demonstrated the wound healing and anti-inflammatory properties of PDRN, which are mediated by the activation of adenosine A2A receptor and salvage pathways, in addition to promoting osteoblast activity, collagen synthesis, and angiogenesis. In fact, PDRN is already marketed due to its therapeutic properties against various wound healing- and inflammation-related diseases. Therefore, this review assessed the most recent trends in marine organism-derived PDRN using the Google Scholar search engine. Further, we summarized the current applications and pharmacological properties of PDRN to serve as a reference for the development of novel PDRN-based technologies.

The dry process is a promising fabrication method for all‐solid‐state batteries (ASSBs) to eliminate energy‐intense drying and solvent recovery steps and to prevent degradation of solid‐state electrolytes (SSEs) in the wet process. While previous studies have utilized the dry process to enable thin SSE films, systematic studies on their fabrication, physical and electrochemical properties, and electrochemical performance are unprecedented. Here, different fabrication parameters are studied to understand polytetrafluoroethylene (PTFE) binder fibrillation and its impact on the physio‐electrochemical properties of SSE films, as well as the cycling stability of ASSBs resulting from such SSEs. A counter‐balancing relation between the physio‐electrochemical properties and cycling stability is observed, which is due to the propagating behavior of PTFE reduction (both chemically and electrochemically) through the fibrillation network, resulting in cell failure from current leakage and ion blockage. By controlling PTFE fibrillation, a bilayer configuration of SSE film to enable physio‐electrochemically durable SSE film for both good cycling stability and charge storage capability of ASSBs is demonstrated.

No abstract

No abstract

Vocal fold fibrosis is an abnormal condition characterized by unfavorable changes in the organization of the extracellular matrix in vocal fold lamina propria. To prevent and treat vocal fold fibrosis, a number of synthetic drugs, such as mitomycin C and the glucocorticoid family, are used after surgery, but these are known to have some side effects. Therefore, using both in vitro and in vivo studies, this study investigated whether phlorotannins extracted from Ecklonia cava have the potential to prevent vocal fold fibrosis with minimal side effects. The results show that phlorotannins suppressed both the expression of the fibrotic phenotypic marker and cell migration by inhibiting the activation of the mitogen‐activated protein kinase (MAPK) and Smad2/3 signaling pathways in human vocal fold fibroblasts stimulated by transforming growth factor‐β. Additionally, phlorotannins exhibited antifibrotic efficacy without an excessive inflammatory response in a laser‐induced fibrosis rabbit model when delivered as an aerosol via inhalation. Based on these results, phlorotannins should be considered a promising candidate for use in the prevention of vocal fold fibrosis.